News
What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and ...
Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent ...
Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...
Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an ...
Driving growth in a family-owned pharma company requires a balance of progress and preservation, writes Merz Therapeutics CEO ...
<p> Suvoda and Greenphire have announced the successful completion of their previously announced merger. Through this merger, the combined company is now better equipped to provide a ...
Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound. According to NVIDIA, Agentic AI will ...
<p>On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, ...
This week's episode is one from the road, recorded in front of a live audience in Boston's Seaport neighborhood during the BIO conference (special thanks to MasterControl for making it happen). Amber ...
A client in Ireland acquired an aseptic operations facility with plans to expand into GMP microbiology laboratory services, despite having previously outsourced all microbiology work and lacking ...
A large manufacturing client in the southeastern U.S. chose to outsource its laboratory operations to focus on its core business strategy, which involved displacing around 100 employees. To address ...
A major biopharmaceutical company faced equity and operational challenges from relying on temporary employees in long-term roles. These workers lacked full-time status and received limited, costly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback